144 related articles for article (PubMed ID: 35357080)
1. Disparities in radiation therapy utilization for cancer patients in Victoria.
Ong WL; Finn N; Te Marvelde L; Hornby C; Milne RL; Hanna GG; Pitson G; Elsaleh H; Millar JL; Foroudi F
J Med Imaging Radiat Oncol; 2022 Sep; 66(6):830-839. PubMed ID: 35357080
[TBL] [Abstract][Full Text] [Related]
2. Changing pattern of radiation therapy for bone metastases in an Australian population-based cohort of men with prostate cancer.
Ong WL; Milne RL; Foroudi F; Millar JL
Clin Genitourin Cancer; 2022 Feb; 20(1):e7-e15. PubMed ID: 34366292
[TBL] [Abstract][Full Text] [Related]
3. Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study.
Shack L; Lu S; Weeks LA; Craighead P; Kerba M
Radiother Oncol; 2017 Jan; 122(1):152-158. PubMed ID: 28012795
[TBL] [Abstract][Full Text] [Related]
4. Choosing Wisely in radiation therapy for breast cancer: Time lag in adoption of hypofractionated radiation therapy in Victoria.
Ong WL; Khor R; Chao M; Milne RL; Millar J; Foroudi F
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):224-232. PubMed ID: 33591610
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of patient-reported quality of life outcomes after external beam radiation treatment for prostate cancer in Victoria: A cohort study by the Victorian Prostate Cancer Registry.
Patabendi Bandarage VR; Billah B; Millar JL; Evans S
J Med Imaging Radiat Oncol; 2016 Jun; 60(3):420-7. PubMed ID: 26763604
[TBL] [Abstract][Full Text] [Related]
6. Provincial variations in radiotherapy utilization as a measure of access: A pan-Canadian study.
Chan J; Brown E; Dennis K; Milosevic M; Brundage M
Radiother Oncol; 2022 Feb; 167():122-126. PubMed ID: 34942281
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000.
Johnston GM; MacGarvie VL; Elliott D; Dewar RA; MacIntyre MM; Nolan MC
Clin Invest Med; 2004 Jun; 27(3):142-56. PubMed ID: 15305806
[TBL] [Abstract][Full Text] [Related]
8. Variation in the Use of Single- Versus Multifraction Palliative Radiation Therapy for Bone Metastases in Australia.
Ong WL; Foroudi F; Milne RL; Millar JL
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):61-66. PubMed ID: 31505246
[TBL] [Abstract][Full Text] [Related]
9. Are We Choosing Wisely in Radiation Oncology Practice-Findings From an Australian Population-Based Study.
Ong WL; Foroudi F; Milne RL; Millar JL
Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1012-1016. PubMed ID: 30981834
[TBL] [Abstract][Full Text] [Related]
10. Increasing use of post-mastectomy hypofractionated radiation therapy for breast cancer in Victoria.
Kim S; Pitson G; Koh TL; Chao M; Byrne K; Hornby C; Foroudi F; Millar J; Ong WL
J Med Imaging Radiat Oncol; 2022 Apr; 66(3):428-435. PubMed ID: 34811941
[TBL] [Abstract][Full Text] [Related]
11. Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer.
Ong WL; Foroudi F; Evans S; Millar J
BJU Int; 2017 Nov; 120 Suppl 3():35-42. PubMed ID: 28749017
[TBL] [Abstract][Full Text] [Related]
12. Geographical access to radiation therapy in North Queensland: a retrospective analysis of patient travel to radiation therapy before and after the opening of an additional radiotherapy facility.
Sharma DK; Vangaveti VN; Larkins S
Rural Remote Health; 2016; 16(1):3640. PubMed ID: 26960266
[TBL] [Abstract][Full Text] [Related]
13. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002.
Vulto AJ; Lemmens VE; Louwman MW; Janssen-Heijnen ML; Poortmans PH; Lybeert ML; Coebergh JW
Cancer; 2006 Jun; 106(12):2734-42. PubMed ID: 16703598
[TBL] [Abstract][Full Text] [Related]
14. Age disparity in palliative radiation therapy among patients with advanced cancer.
Wong J; Xu B; Yeung HN; Roeland EJ; Martinez ME; Le QT; Mell LK; Murphy JD
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):224-30. PubMed ID: 25195994
[TBL] [Abstract][Full Text] [Related]
15. Differences in treatment choices for localised prostate cancer diagnosed in private and public health services.
Te Marvelde L; Milne RL; Hornby CJ; Chapman AB; Giles GG; Haines IE
Med J Aust; 2020 Nov; 213(9):411-417. PubMed ID: 32996611
[TBL] [Abstract][Full Text] [Related]
16. The impact of sociodemographic factors on the utilization of radiation therapy in breast cancer patients in Estonia: a register-based study.
Shahrabi Farahani F; Paapsi K; Innos K
Int J Equity Health; 2021 Jun; 20(1):152. PubMed ID: 34193144
[TBL] [Abstract][Full Text] [Related]
17. Palliative radiotherapy for bone metastases at the end of life in Victoria.
Ong WL; Foroudi F; Milne RL; Millar JL
Med J Aust; 2021 Mar; 214(5):236-237.e1. PubMed ID: 33610136
[No Abstract] [Full Text] [Related]
18. [Trends in the use of primary radiotherapy for cancer in the Netherlands in patients with breast, prostate, rectal and lung tumours].
Struikmans H; Aarts MJ; Jobsen JJ; Koning CC; Poortmans PM; Louwman MW; Coebergh JW
Ned Tijdschr Geneeskd; 2012; 156(12):A4426. PubMed ID: 22436526
[TBL] [Abstract][Full Text] [Related]
19. The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry.
Weerakoon M; Papa N; Lawrentschuk N; Evans S; Millar J; Frydenberg M; Bolton D; Murphy DG
BJU Int; 2015 Apr; 115 Suppl 5():50-6. PubMed ID: 25601201
[TBL] [Abstract][Full Text] [Related]
20. Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy.
Ong WL; Evans SM; Millar JL
J Med Imaging Radiat Oncol; 2018 Apr; 62(2):256-261. PubMed ID: 29271056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
